Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

States argue that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold ...

Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

Twenty-seven states and Washington, D.C., have filed a lawsuit to block the sale of customers’ DNA and data without their ...

New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information after the genetic testing company filed for bankruptcy in March.

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

The California-based company, which allowed customers to learn about their ancestry by submitting saliva samples in the mail, ...

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without ...